Day 3 Updates: Artificial Intelligence & Novel Therapeutics

Welcome back to our ongoing coverage of the ESC 2026 Congress in Munich. Our Day 3 updates highlight the transformative role of artificial intelligence in cardiac magnetic resonance imaging and novel therapeutic strategies targeting the renin-angiotensin-aldosterone system[cite: 4]. You will also find comprehensive analyses on the use of salt substitutes in chronic kidney disease and the latest clinical evidence regarding metformin in heart failure[cite: 4].

Furthermore, we explore pragmatic strategies for successful guideline-directed medical therapy implementation, including the promising POLY-HF polypill trial designed to reduce treatment complexity[cite: 4].

Click below to download the detailed highlights.